2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis

Abstract

Purpose: Previous positron emission tomography (PET) studies have shown increased 2-deoxy-2-[18F]fluoro-D-glucose (FDG) uptake in joints of patients with osteoarthritis (OA) and inflamed joints of patients with rheumatoid arthritis (RA). This study compares FDG uptake in joints of RA and OA patients and FDG-uptake with clinical signs of inflammation. Procedures: FDG-PET scans of hands and wrists were performed in patients with RA and primary OA. PET data were compared with clinical data. Results: 29% of RA joints and 6% of OA joints showed elevated FDG-uptake. The level of uptake in PET-positive OA joints was not significantly different from that in RA joints. The majority of PET results of RA joints corresponded with clinical findings. Clinical synovitis was found some OA joints with FDG-uptake. Conclusions: FDG-uptake was observed in the majority of clinically inflamed RA joints and in a few OA joints with no significant difference in uptake level. The latter may be due to secondary synovitis.

High-resolution18F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study

“…11,12 Currently available whole-body PET/ CT scanners-optimized for imaging large regions of the bodyare suboptimal for quantifying radiotracer concentration (and hence, disease activity) for the small joints of the hand and wrist. 5,13 This is attributed to their relatively limited spatial resolution and resulting partial volume effect that limits quantification capability. Systems capable of limited-angle acquisition, such as the positron emission mammography Flex Solo II, also have a compromised ability for radiotracer activity quantification.…”

Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis

“…It involves loss of bone and cartilage and inflammation of the synovium. Various studies have been performed to investigate the usefulness of PET using [ 18 F]FDG for diagnosis of RA [1][2][3][4]. As RA is an inflammatory disease, tracers that bind to the peripheral benzodiazepine receptor (PBR), also called omega-3 receptor, which is expressed on macrophages, may be of even more interest.…”

18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study

“…Several reports have shown that inflammation in synovial tissue in RA patients can be detected using 18 F-FDG PET (8)(9)(10)(11)(12). Therefore, 18 F-FDG PET may be an interesting tool to assess response early during anti-TNF treatment.…”